KL and neoplasm: In fact, the peptide KLA (acetyl-KLAKLAK)2-NH2) conjugated with a tumor-homing peptide iRGD (CRGDKGPDC) has improved penetration of low-grade tumor tissue and cells with high selectivity and low systemic toxicity [42,183].